Panostok-CT Capsule ER is a combination medication used to treat gastro-oesophageal reflux disease (GERD), indigestion, duodenal ulcers, erosive oesophagitis (acid-related damage to the lining of the oesophagus), infections caused by Helicobacter pylori when given along with an antibiotic, and Zollinger-Ellison syndrome. The stomach is usually protected from acid by a mucous layer. In some cases, due to excess acid production, the mucous layer gets eroded, which leads to complications like GERD, acidity, and peptic ulcers.

Panostok-CT Capsule ER contains Pantoprazole and Cinitapride. Pantoprazole works by blocking the action of an enzyme called gastric proton pump, which is responsible for the production of stomach acid. Cinitapride increases the pressure of the inferior oesophageal sphincter, thereby preventing the back-flow of food and acid from the stomach into the mouth. Together, Panostok-CT Capsule ER helps in preventing acid reflux, thereby providing relief from acidity and heartburn. 

You are advised to take Panostok-CT Capsule ER for as long as your doctor has prescribed it for you, depending on your medical condition. In some cases, you may experience certain common side effects, such as headache, flatulence, stomach pain, constipation, and diarrhoea. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side effects persistently.

Consult your doctor if you are pregnant or breastfeeding. Panostok-CT Capsule ER may cause dizziness, so drive only if you are alert. Panostok-CT Capsule ER should not be given to children as safety has not been established. Avoid consuming alcohol along with Panostok-CT Capsule ER as it could lead to increased drowsiness and can elevate the production of stomach acid. Keep your doctor informed about all the medicines and your health condition to rule out any side effects.

Panostok-CT Capsule ER is a combination medicine used to treat gastro-oesophageal reflux disease (GERD), indigestion, duodenal ulcers, erosive oesophagitis (acid-related damage to the lining of the oesophagus), infections caused by Helicobacter pylori when given along with an antibiotic, and Zollinger-Ellison syndrome. Panostok-CT Capsule ER is a combination of two drugs: Pantoprazole and Cinitapride. Pantoprazole is a proton pump inhibitor that works by blocking the action of an enzyme called the gastric proton pump, which is responsible for the production of acid. Cinitapride is a gastro-prokinetic agent which increases the pressure of the inferior oesophageal sphincter, thereby preventing the back-flow of food and acid from the stomach into the mouth. Together, Panostok-CT Capsule ER helps in preventing acid reflux, thereby providing relief from acidity. Panostok-CT Capsule ER increases gastrointestinal motility by enhancing the strength of contractions without disrupting their rhythm; thus, it helps treat indigestion.

Do not take Panostok-CT Capsule ER if you are allergic to any of its contents. Inform your doctor before taking Panostok-CT Capsule ER if you have severe liver or kidney problems and if you are due to have a Chromogranin A test. Consult your doctor if you experience unexplained weight loss, stomach pain, indigestion, vomit food or blood, or if you pass black stools. On long-term treatment, Panostok-CT Capsule ER may cause osteoporosis and hypomagnesemia (low levels of magnesium) and may reduce the absorption of vitamin B12. Consult your doctor if you are pregnant or breastfeeding. Panostok-CT Capsule ER may cause dizziness, so drive only if you are alert. Panostok-CT Capsule ER should not be given to children as safety has not been established. Avoid consuming alcohol along with Panostok-CT Capsule ER as it could lead to increased drowsiness and can elevate the production of stomach acid. Keep your doctor informed about all the medicines and your health condition to rule out any side effects.